Recent Updates
Recently added Catalysts
MDAI Positive Sentiment

Spectral AI to Participate in Benzinga’s “AI Unleashed: Exploring the Possibilities” Virtual Event

Key Takeaway: Spectral AI, Inc. (Nasdaq: MDAI) announced its participation in Benzinga's 'AI Unleashed: Exploring the Possibilities' virtual event on May 30, 2024. CEO Peter M. Carlson will engage in a fireside chat, discussing the company's innovative approaches in medical diagnostics, specifically for wound care. Spectral AI's DeepView System is designed to provide faster, objective assessments of wound healing potential, potentially improving patient outcomes and reducing healthcare costs. The event is accessible live, and a webcast will also be available for interested parties.
Price reaction · baseline $1.62 (2024-05-24 close) · hit after-hours · 1 other MDAI headline(s) in the window, move may be shared
day 0 close · peak
-0.6%

Market Sentiment Analysis

POSITIVE FACTORS

  • Spectral AI is participating in a prominent virtual event, increasing visibility.
  • The company is focused on innovative medical diagnostics, promising improved patient care.
  • DeepView System aims to revolutionize wound care management, enhancing treatment accuracy.

Full Press Release Details

DALLAS, May 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Peter M. Carlson, Chief Executive Officer of Spectral AI, is scheduled to participate in a fireside chat at Benzinga’s “AI Unleashed: Exploring the Possibilities” virtual event, taking place on May 30, 2024.
The fireside chat will begin at 11:25 am ET and can be accessed live here. Interested parties may also access the live and archived webcast of the event by visiting the Investors section of Spectral AI’s website at https://investors.spectral-ai.com/news-events/events.
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. DeepView is a predictive medical device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, DeepView is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about DeepView, visit www.spectral-ai.com.
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.
These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
Investors:
The Equity Group Devin Sullivan Managing Director dsullivan@equityny.com Conor Rodriguez Analyst crodriguez@equityny.com
Media:
Russo Partners David Schull Russo Partners (858) 717-2310 david.schull@russopartnersllc.com

Frequently Asked Questions

What company is participating in the Benzinga event?

Spectral AI, Inc. is participating in the Benzinga event.

What is the focus of Spectral AI's technology?

Spectral AI focuses on predictive AI for medical diagnostics in wound care.

When is the fireside chat scheduled?

The fireside chat is on May 30, 2024, at 11:25 am ET.

What is the DeepView System used for?

DeepView assesses a wound's healing potential for better treatment decisions.

Where can I find more information about DeepView?

More information about DeepView is available at www.spectral-ai.com.

Last updated: May 28, 2024